253 related articles for article (PubMed ID: 18618666)
1. Uric acid in Parkinson's disease.
Schlesinger I; Schlesinger N
Mov Disord; 2008 Sep; 23(12):1653-7. PubMed ID: 18618666
[TBL] [Abstract][Full Text] [Related]
2. Serum uric acid levels in patients with Parkinson's disease: their relationship to treatment and disease duration.
Andreadou E; Nikolaou C; Gournaras F; Rentzos M; Boufidou F; Tsoutsou A; Zournas C; Zissimopoulos V; Vassilopoulos D
Clin Neurol Neurosurg; 2009 Nov; 111(9):724-8. PubMed ID: 19632030
[TBL] [Abstract][Full Text] [Related]
3. Low plasma uric acid level in Parkinson's disease.
Annanmaki T; Muuronen A; Murros K
Mov Disord; 2007 Jun; 22(8):1133-7. PubMed ID: 17443703
[TBL] [Abstract][Full Text] [Related]
4. Serological profiles of urate, paraoxonase-1, ferritin and lipid in Parkinson's disease: changes linked to disease progression.
Ikeda K; Nakamura Y; Kiyozuka T; Aoyagi J; Hirayama T; Nagata R; Ito H; Iwamoto K; Murata K; Yoshii Y; Kawabe K; Iwasaki Y
Neurodegener Dis; 2011; 8(4):252-8. PubMed ID: 21282940
[TBL] [Abstract][Full Text] [Related]
5. Association of serum uric acid levels with the progression of Parkinson's disease in Chinese patients.
Sun CC; Luo FF; Wei L; Lei M; Li GF; Liu ZL; LE WD; Xu PY
Chin Med J (Engl); 2012 Feb; 125(4):583-7. PubMed ID: 22490478
[TBL] [Abstract][Full Text] [Related]
6. Nigral glutathione deficiency is not specific for idiopathic Parkinson's disease.
Fitzmaurice PS; Ang L; Guttman M; Rajput AH; Furukawa Y; Kish SJ
Mov Disord; 2003 Sep; 18(9):969-76. PubMed ID: 14502663
[TBL] [Abstract][Full Text] [Related]
7. The contributions of antioxidant activity of lipoic acid in reducing neurogenerative progression of Parkinson's disease: a review.
De Araújo DP; Lobato Rde F; Cavalcanti JR; Sampaio LR; Araújo PV; Silva MC; Neves KR; Fonteles MM; Sousa FC; Vasconcelos SM
Int J Neurosci; 2011 Feb; 121(2):51-7. PubMed ID: 21126109
[TBL] [Abstract][Full Text] [Related]
8. [Do antioxidants in the diet affect the risk of developing Parkinson disease?].
Jiménez-Jiménez FJ; Ayuso-Peralta L; Molina JA; Cabrera-Valdivia F
Rev Neurol; 1999 Oct 16-31; 29(8):741-4. PubMed ID: 10560110
[TBL] [Abstract][Full Text] [Related]
9. Higher serum uric acid associated with decreased Parkinson's disease prevalence in a large community-based survey.
Winquist A; Steenland K; Shankar A
Mov Disord; 2010 May; 25(7):932-6. PubMed ID: 20310031
[TBL] [Abstract][Full Text] [Related]
10. [Study on uric acid and the related factors associated with cognition in the patients with Parkinson's disease].
Wang XJ; Luo WF; Wang LJ; Mao CJ; Wang L; Liu CF
Zhonghua Yi Xue Za Zhi; 2009 Jun; 89(23):1633-5. PubMed ID: 19957513
[TBL] [Abstract][Full Text] [Related]
11. Uric acid associates with cognition in Parkinson's disease.
Annanmaki T; Pessala-Driver A; Hokkanen L; Murros K
Parkinsonism Relat Disord; 2008 Nov; 14(7):576-8. PubMed ID: 18321759
[TBL] [Abstract][Full Text] [Related]
12. Altered uric acid levels and disease states.
Kutzing MK; Firestein BL
J Pharmacol Exp Ther; 2008 Jan; 324(1):1-7. PubMed ID: 17890445
[TBL] [Abstract][Full Text] [Related]
13. Urate in Parkinson's disease: more than a biomarker?
Chen X; Wu G; Schwarzschild MA
Curr Neurol Neurosci Rep; 2012 Aug; 12(4):367-75. PubMed ID: 22580741
[TBL] [Abstract][Full Text] [Related]
14. Genetic variability related to serum uric acid concentration and risk of Parkinson's disease.
González-Aramburu I; Sánchez-Juan P; Jesús S; Gorostidi A; Fernández-Juan E; Carrillo F; Sierra M; Gómez-Garre P; Cáceres-Redondo MT; Berciano J; Ruiz-Martínez J; Combarros O; Mir P; Infante J
Mov Disord; 2013 Oct; 28(12):1737-40. PubMed ID: 23712608
[TBL] [Abstract][Full Text] [Related]
15. [Metals and oxidative stress in Parkinson's disease from industrial areas with exposition to environmental toxins or metal pollution].
Squitti R; Gorgone G; Binetti G; Ghidoni R; Pasqualetti P; Draicchio F; Albini E; Benedetti L; Lucchini R; Rossini PM
G Ital Med Lav Ergon; 2007; 29(3 Suppl):294-6. PubMed ID: 18409692
[TBL] [Abstract][Full Text] [Related]
16. Re: "plasma urate and risk of Parkinson's disease".
Wise BL; Neogi T; Zhang Y
Am J Epidemiol; 2008 Mar; 167(6):752-3; author reply 753-4. PubMed ID: 18283033
[No Abstract] [Full Text] [Related]
17. Antioxidants, supplements, and Parkinson's disease.
Weber CA; Ernst ME
Ann Pharmacother; 2006 May; 40(5):935-8. PubMed ID: 16622156
[TBL] [Abstract][Full Text] [Related]
18. Oral Inosine Persistently Elevates Plasma antioxidant capacity in Parkinson's disease.
Bhattacharyya S; Bakshi R; Logan R; Ascherio A; Macklin EA; Schwarzschild MA
Mov Disord; 2016 Mar; 31(3):417-21. PubMed ID: 26805433
[TBL] [Abstract][Full Text] [Related]
19. Serum cholesterol levels and the risk of Parkinson's disease.
de Lau LM; Koudstaal PJ; Hofman A; Breteler MM
Am J Epidemiol; 2006 Nov; 164(10):998-1002. PubMed ID: 16905642
[TBL] [Abstract][Full Text] [Related]
20. Targeting urate to reduce oxidative stress in Parkinson disease.
Crotty GF; Ascherio A; Schwarzschild MA
Exp Neurol; 2017 Dec; 298(Pt B):210-224. PubMed ID: 28622913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
